Zybiraa 250Mg Tablet

Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Zybiraa 250Mg Tablet also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include:
Groin pain
Irregular heart rate
Blood in urine
Yellowing of skin and eyes
Bleeding
Unusual bruising
Swelling of joints
Diarrhea
Constipation
Trouble sleeping
Heartburn
Hot flashes
Contact your doctor immediately if you experience any severe or unusual side effects.

The dosage of Zybiraa 250Mg Tablet is determined by the doctor as per the stage of cancer and other health factors of the patient. The medicine should be taken orally on an empty stomach or can be consumed one hour before or two hours after a meal. In case of an overdose, contact your doctor immediately.

It is advisable to avoid missing any dose. In case, you missed a dose of Zybiraa 250mg tablet consult your doctor immediately.

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1.Kumar, S., Joshi, A., Takke, A., Varghese, D., Pathak, S., Noronha, V., ... & Gota, V. (2025). Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis. Indian Journal of Medical and Paediatric Oncology.
2. Rehman, Y., & Rosenberg, J. E. (2012). Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer. Drug design, development and therapy, 13-18.
3.Scott, L. J. (2017). Abiraterone acetate: a review in metastatic castration-resistant prostrate cancer. Drugs, 77(14), 1565-1576.
4. Buikin, P., Vologzhanina, A., Novikov, R., Dorovatovskii, P., & Korlyukov, A. (2023). Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding. Pharmaceutics, 15(9), 2180.
5. Salem, M., & Garcia, J. A. (2011). Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer. Current oncology reports, 13(2), 92-96.